Next 10 |
home / stock / mnkkq / mnkkq news
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire DUBLIN , Aug. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced today that it wil...
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire Appoints Sigurdur Olafsson as President and Chief Executive Officer DUBLIN, Ireland , June 16, 2022 /PRNewswire/ -- Mallinckr...
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome PR Newswire DUBLIN , June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced the ...
Mallinckrodt (OTCPK:MNKKQ) expects to emerge out of bankruptcy in the coming days. The pharmaceutical company is likely to its reorganization process, emerge from Chapter 11 bankruptcy protection and complete the Irish Examinership proceedings over the coming days. All of Mallinckrodt's exist...
Mallinckrodt Announces Anticipated Chapter 11 Emergence and Provides Update on Trading of New Ordinary Shares PR Newswire DUBLIN , June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ) (" Mallinckrodt " or the "Company") today announced ...
Founded in 2006 by Morty Schaja and Mitch Rubin, RiverPark manages research-driven, focused strategies in equities, fixed income and venture capital. Called and Tendered securities continue to be a significant component of our purchases. The supply of these bonds remained ample during...
New Retrospective Data on African Americans with Advanced Symptomatic Sarcoidosis Treated with Acthar® Gel (Repository Corticotropin Injection) Presented at the American Thoracic Society Annual International Conference PR Newswire Retrospective medical chart revie...
High Court of Ireland Confirms Mallinckrodt Scheme of Arrangement PR Newswire Company Expects to Complete Irish Examinership and Emerge from Chapter 11 in the Next Few Weeks DUBLIN , April 27, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MN...
Mallinckrodt (NYSE:MNK) (OTCPK:MNKKQ) reported data from a retrospective chart review study evaluating the real-world use INOmax (nitric oxide) gas for inhalation in hospitalized patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome, in the U.S. The results of the st...
Mallinckrodt Announces Publication of Real-World Data from Retrospective Study on the Investigational Use of Inhaled Nitric Oxide in Hospitalized COVID-19 Patients PR Newswire – Medical chart review study, published in Drugs in Context , evaluated the rea...
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt plc Company Name:
MNKKQ Stock Symbol:
OTCMKTS Market:
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire DUBLIN , Aug. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced today that it wil...
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire Appoints Sigurdur Olafsson as President and Chief Executive Officer DUBLIN, Ireland , June 16, 2022 /PRNewswire/ -- Mallinckr...
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome PR Newswire DUBLIN , June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced the ...